WallStreetZenWallStreetZen

NASDAQ: OCX
Oncocyte Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for OCX

Based on 4 analysts offering 12 month price targets for Oncocyte Corp.
Min Forecast
$3.00+17.19%
Avg Forecast
$3.90+52.34%
Max Forecast
$5.00+95.31%

Should I buy or sell OCX stock?

Based on 4 analysts offering ratings for Oncocyte Corp.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 50%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OCX stock forecasts and price targets.

OCX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2023-11-13
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is OCX forecast to generate an efficient return?
Company
113.17%
Industry
-4.62%
Market
32.84%
OCX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OCX forecast to generate an efficient return on assets?
Company
30.93%
Industry
10.84%
OCX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OCX revenue forecast

What is OCX's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$2.9M+92.95%

OCX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
OCX$2.56$3.90+52.34%Buy
DMTK$0.59$1.75+196.11%Buy
MYNZ$0.90$3.00+231.86%Buy
XGN$1.43N/AN/A
TTOO$2.99N/AN/A
View Top Diagnostic & Research Stocks

Oncocyte Stock Forecast FAQ

Is Oncocyte Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OCX) stock is to Buy OCX stock.

Out of 4 analysts, 0 (0%) are recommending OCX as a Strong Buy, 2 (50%) are recommending OCX as a Buy, 2 (50%) are recommending OCX as a Hold, 0 (0%) are recommending OCX as a Sell, and 0 (0%) are recommending OCX as a Strong Sell.

If you're new to stock investing, here's how to buy Oncocyte stock.

What is OCX's revenue growth forecast for 2024-2024?

(NASDAQ: OCX) Oncocyte's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Oncocyte's revenue in 2024 is $1,503,000.

In 2024, OCX is forecast to generate $23,991,912 in revenue, with the lowest revenue forecast at $23,991,912 and the highest revenue forecast at $23,991,912.

What is OCX's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: OCX) forecast ROA is 30.93%, which is higher than the forecast US Diagnostics & Research industry average of 10.84%.

What is OCX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OCX price target, the average OCX price target is $3.90, with the highest OCX stock price forecast at $5.00 and the lowest OCX stock price forecast at $3.00.

On average, Wall Street analysts predict that Oncocyte's share price could reach $3.90 by Apr 17, 2025. The average Oncocyte stock price prediction forecasts a potential upside of 52.34% from the current OCX share price of $2.56.

What is OCX's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: OCX) forecast ROE is 113.17%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.